Description
Drug Info: ApoThera Drug Disease Clinical Support App
Administration
– Inject subcutaneously in the upper arm, thigh, or abdomen.
– Do not inject intravenously or intramuscularly.
– Administer without regard to meals or time of day.
– Change needle with each administration.
– Use only if clear, colorless, and free of particulate matter.
– Do not share pens between patients even if needle is changed
– If using concomitantly with insulin, administer as separate injections (do not mix); may inject in the same body region as insulin, but not adjacent to one another.
Storage
– Prior to initial use, store at 2°C to 8°C (36°F to 46°F); after initial use, may be stored at 2°C to 8°C (36°F to 46°F) or at 15°C to 30°C (59°F to 86°F)
– Do not freeze (discard if freezing occurs) or store directly adjacent to the refrigerator cooling element
– Protect from heat and light
– Pen should be discarded 30 days after initial use.
Monitoring
– Plasma glucose, HbA1c (at least twice yearly in patients who have stable glycemic control and are meeting treatment goals
– Quarterly in patients not meeting treatment goals or with therapy change
– Renal function
– Signs/symptoms of pancreatitis
– Triglycerides
– Signs/symptoms of gallbladder disease
– Emergence of worsening depression, suicidal thoughts/behavior, changes in behavior
– Heart rate
– Body weight (at week 16 when used for chronic weight management)
Find a Physician for Weight Loss or Diabetes (Saxenda 18mg/3mL)
